Cargando…

Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson’s disease – a multicenter study

BACKGROUND: The transcription factor Nrf2, encoded by the NFE2L2 gene, is an important regulator of the cellular protection against oxidative stress. Parkinson’s disease is a neurodegenerative disease highly associated with oxidative stress. In a previously published study, we reported associations...

Descripción completa

Detalles Bibliográficos
Autores principales:	von Otter, Malin, Bergström, Petra, Quattrone, Aldo, De Marco, Elvira Valeria, Annesi, Grazia, Söderkvist, Peter, Wettinger, Stephanie Bezzina, Drozdzik, Marek, Bialecka, Monika, Nissbrandt, Hans, Klein, Christine, Nilsson, Michael, Hammarsten, Ola, Nilsson, Staffan, Zetterberg, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335439/ https://www.ncbi.nlm.nih.gov/pubmed/25496089 http://dx.doi.org/10.1186/s12881-014-0131-4

Ejemplares similares

Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease
por: von Otter, Malin, et al.
Publicado: (2010)

Transcription factor NFE2L2/NRF2 is a regulator of macroautophagy genes
por: Pajares, Marta, et al.
Publicado: (2016)

Patient-Derived Mutant Forms of NFE2L2/NRF2 Drive Aggressive Murine Hepatoblastomas
por: Wang, Huabo, et al.
Publicado: (2021)

Combination of autophagy and NFE2L2/NRF2 activation as a treatment approach for neuropathic pain
por: Li, Jian, et al.
Publicado: (2021)

Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder
por: Huppke, Peter, et al.
Publicado: (2017)

The Regulation of NFE2L2 (NRF2) Signalling and Epithelial-to-Mesenchymal Transition in Age-Related Macular Degeneration Pathology
por: Hyttinen, Juha M. T., et al.
Publicado: (2019)

Developmental Expression of the Nfe2-Related Factor (Nrf) Transcription Factor Family in the Zebrafish, Danio rerio
por: Williams, Larissa M., et al.
Publicado: (2013)

Transcription factor NFE2L2/NRF2 modulates chaperone-mediated autophagy through the regulation of LAMP2A
por: Pajares, Marta, et al.
Publicado: (2018)

The Effects of Nuclear Factor Erythroid 2 (NFE2)-Related Factor 2 (Nrf2) Activation in Preclinical Models of Peripheral Neuropathic Pain
por: Basu, Paramita, et al.
Publicado: (2022)

Multiple regulatory mechanisms of the biological function of NRF3 (NFE2L3) control cancer cell proliferation
por: Chowdhury, A. M. Masudul Azad, et al.
Publicado: (2017)

Anti-cancer and potential chemopreventive actions of ginseng by activating Nrf2 (NFE2L2) anti-oxidative stress/anti-inflammatory pathways
por: Saw, Constance Lay-Lay, et al.
Publicado: (2010)

NFE2L2 polymorphisms, mortality, and metabolism in the general population
por: Figarska, Sylwia M., et al.
Publicado: (2014)

β-Catenin/TCF4 Complex-Mediated Induction of the NRF3 (NFE2L3) Gene in Cancer Cells
por: Aono, Shiori, et al.
Publicado: (2019)

NFE2L2/NRF2 silencing-inducible miR-206 targets c-MET/EGFR and suppresses BCRP/ABCG2 in cancer cells
por: Choi, Bo-Hyun, et al.
Publicado: (2017)

Proteomic Analysis Reveals a Predominant NFE2L2 (NRF2) Signature in Canonical Pathway and Upstream Regulator Analysis of Leishmania-Infected Macrophages
por: de Menezes, Juliana Perrone Bezerra, et al.
Publicado: (2019)

Genetic causes of Parkinson’s disease in the Maltese: a study of selected mutations in LRRK2, MTHFR, QDPR and SPR
por: Zahra, Charmaine, et al.
Publicado: (2016)

Functional Polymorphism in the NFE2L2 Gene Associated With Tuberculosis Susceptibility
por: Ji, Guiyi, et al.
Publicado: (2021)

Association of the RAGE G82S polymorphism with Alzheimer’s disease
por: Daborg, Jonny, et al.
Publicado: (2010)

Ferroptosis regulation by the NGLY1/NFE2L1 pathway
por: Forcina, Giovanni C., et al.
Publicado: (2022)

NFE2L2 variations reduce antioxidant response in patients with Parkinson disease
por: Gui, YaXing, et al.
Publicado: (2016)

The Role of Nrf2 in Pathology of Pleomorphic Adenoma in Parotid Gland
por: Droździk, Agnieszka, et al.
Publicado: (2015)

Interaction of Genetic Variations in NFE2L2 and SELENOS Modulates the Risk of Hashimoto's Thyroiditis
por: Santos, Liliana R., et al.
Publicado: (2019)

Effects of trehalose on NFE2L2, catalase, and superoxide dismutase in the kidney of aged rats
por: Hozhabri, Yaser, et al.
Publicado: (2022)

Genetic variation in NFE2L2 is associated with outcome following aneurysmal subarachnoid haemorrhage
por: Gaastra, Ben, et al.
Publicado: (2022)

Involvement of a Transcription factor, Nfe2, in Breast Cancer Metastasis to Bone
por: Zhang, Di, et al.
Publicado: (2020)

NFE2L1-mediated proteasome function protects from ferroptosis
por: Kotschi, Stefan, et al.
Publicado: (2022)

Unravelling the role of NFE2L1 in stress responses and related diseases
por: Liu, Xingzhu, et al.
Publicado: (2023)

Differences in Anxiety-Like Behavior within a Batch of Wistar Rats Are Associated with Differences in Serotonergic Transmission, Enhanced by Acute SRI Administration, and Abolished By Serotonin Depletion
por: Näslund, Jakob, et al.
Publicado: (2015)

RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2/NRF2 in an m(6)A‐IGF2BP2‐dependent manner
por: Ye, Jing, et al.
Publicado: (2022)

The transcription factor NRF1 (NFE2L1) activates aggrephagy by inducing p62 and GABARAPL1 after proteasome inhibition to maintain proteostasis
por: Hatanaka, Atsushi, et al.
Publicado: (2023)

Hepatic Nfe2l2 Is Not an Essential Mediator of the Metabolic Phenotype Produced by Dietary Methionine Restriction
por: Fang, Han, et al.
Publicado: (2021)

Regulation of VEGFA, KRAS, and NFE2L2 Oncogenes by MicroRNAs in Head and Neck Cancer
por: Cuzziol, Caroline Izak, et al.
Publicado: (2022)

APOBEC mutagenesis and selection for NFE2L2 contribute to the origin of lung squamous-cell carcinoma
por: Cannataro, Vincent L., et al.
Publicado: (2022)

Role of NFE2L1 in the Regulation of Proteostasis: Implications for Aging and Neurodegenerative Diseases
por: Chandran, Aswathy, et al.
Publicado: (2023)

Transcription Factor NFE2L1 Decreases in Glomerulonephropathies after Podocyte Damage
por: Elshani, Mustafa, et al.
Publicado: (2023)

Immunotherapy with HDC/IL-2 may be clinically efficacious in acute myeloid leukemia of normal karyotype
por: Nilsson, Malin S., et al.
Publicado: (2019)

High CD44 expression mediates p62-associated NFE2L2/NRF2 activation in breast cancer stem cell-like cells: Implications for cancer stem cell resistance
por: Ryoo, In-geun, et al.
Publicado: (2018)

Pharmacogenetics of Parkinson’s Disease – Through Mechanisms of Drug Actions
por: Droździk, Marek, et al.
Publicado: (2013)

A Possible Role for HMG-CoA Reductase Inhibitors and Its Association with HMGCR Genetic Variation in Parkinson’s Disease
por: Pierzchlińska, Anna, et al.
Publicado: (2021)

Level and course of FEV(1 )in relation to polymorphisms in NFE2L2 and KEAP1 in the general population
por: Siedlinski, Mateusz, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3usqgi31ighpraobe78jlhp175